Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.2M Buy
22,732
+10,097
+80% +$1.08M 0.06% 176
2022
Q2
$1.37M Buy
12,635
+3,348
+36% +$380K 0.04% 215
2022
Q1
$1.1M Sell
9,287
-8
-0.1% -$992 0.03% 248
2021
Q4
$1.31M Buy
9,295
+1,575
+20% +$202K 0.03% 220
2021
Q3
$912K Buy
7,720
+1,943
+34% +$239K 0.03% 244
2021
Q2
$670K Buy
5,777
+1,089
+23% +$127K 0.02% 223
2021
Q1
$562K Buy
4,688
+2,781
+146% +$329K 0.03% 199
2020
Q4
$209K Sell
1,907
-193
-9% -$21K 0.02% 235
2020
Q3
$229K Buy
+2,100
New +$213K 0.02% 247

Other funds holding ABT

55I LLC's ABT Position: Q3 2022 in Review

55I LLC increased its Abbott (ABT) stake by 80% in Q3 2022, buying an estimated $1.08M and bringing the position to 22,732 shares worth $2.2M. The position accounts for 0.06% of the portfolio, ranked #176.

55I LLC first reported a position in ABT in Q3 2020 and has held it in 9 quarters since. 2,620 funds tracked by Wall St. Rank hold ABT as of Q3 2022.

  • 55I LLC held 22,732 shares of Abbott worth $2.2M as of Q3 2022.
  • 55I LLC bought 10,097 Abbott shares in Q3 2022, an estimated $1.08M.
  • Abbott made up 0.06% of 55I LLC's portfolio in Q3 2022, its #176 holding.
  • 55I LLC first reported a position in Abbott in Q3 2020 and has held it in 9 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Abbott as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.